Leading Research Sites.
One Connected Network.
equoia Clinical Research unites leading clinical research sites into one connected network, combining trusted investigators, proven operational excellence, and consistent quality standards. Sponsors and CROs benefit from faster startup, timely enrollment, clean data, and expanded access to diverse patient populations.
Numbers Sponsors and CROs Can Verify
400+
Completed
Trials
05
FDA Inspections, Zero 483 Findings
20+
Dedicated
Recruiters
40,000
Research Subjects
(Shared Database)
50+
Phase 1 /
First-in-Human Trials
Advancing Clinical Research Together
FOR SPONSORS & CROs
One Partner for Enrollment, Quality, and Therapeutic Depth
Sequoia has a strong enrollment history, five-inspection FDA record with zero 483 findings, trusted Principal Investigators and a Chief Medical Officer who stays engaged from study startup through close-out. Across every location, we run on shared SOPs, centralized enrollment, and a single CTMS, so multisite studies are activated, executed, and reported as one. We work alongside your clinical operations teams to support their research with proven execution excellence.
FOR STUDY PARTICIPANTS
Find a Clinical Trial Near You
Clinical research can feel intimidating, so we make it simple. Our team guides you through every step, answers your questions, and treats you with genuine care and respect. If you’re exploring clinical trials in Kansas City or Houston, we’re here to help you decide what’s right for you.
Why We’re Sequoia
A sequoia endures because its roots grow together, sharing strength across one connected system. We built Sequoia the same way.
Rooted in over 20 years of clinical research experience, Sequoia has grown into a connected network where sites share standards, systems, and expertise. Sponsors and CROs work with one coordinated research partner, while participants receive trusted, genuine care close to home.
As we grow, adding sites, specialties, or investigators, our roots continue to deepen.
Why Sponsors and CROs Choose Sequoia
Sequoia operates as one integrated clinical research site network, delivering consistent quality, faster startup, accelerated enrollment, and proven execution through shared systems, centralized operations, and experienced investigators. Rather than operating independently, our investigators share expertise across the network to support every study.
Enrollment Performance
20+ dedicated recruiters and a shared database of 40,000 research subjects drive strong enrollment performance, so sponsors reach their targets with greater confidence. Because recruitment is centralized across the network, multiple sites can collectively contribute to a single enrollment goal.
Quality Without Exceptions
Five FDA inspections and zero 483 findings reflect a standard of excellence shared across our entire organization, from our Chief Medical Officer and investigator leadership to our study management, regulatory, quality, clinical, pharmacy, laboratory, and data management teams.
Therapeutic Depth + PI Credentials
Sequoia’s investigators bring deep, documented experience across multiple therapeutic areas:
- GLP-1 / metabolic
- Nephrology
- Vaccines
- Cardiovascular / cardiometabolic
- Gastroenterology
Our investigators share expertise across the network, giving sponsors access to therapeutic depth regardless of study location.
Specialized Infrastructure
A 34-bed inpatient unit, an onsite pharmacy, and a PBMC lab that can process 50+ samples a day have supported 50+ Phase 1 and First-in-Human studies, advancing clinical research across the network.
Leading Investigators.
Specialized Therapeutic Expertise.
Sequoia’s therapeutic area expertise is grounded in experienced, KOL-level investigators who understand both the science and the patient populations required for enrollment and successful study execution. Each therapeutic area is led by a dedicated principal investigator, and through shared protocols and coordinated operations, that expertise is available to sponsors across the entire network.
GLP-1 / Obesity / Metabolic
Dr. Damaris Vega, Dr. Mona Mounla & Dr. Harbison
Supporting obesity, metabolic and endocrine studies across the Sequoia network with 40+ completed obesity and T2DM studies.
Cardiovascular / Cardiometabolic
Dr. Heath Wilt
Supporting hypertension, heart failure and lipid management studies across the Sequoia network.
Nephrology
Dr. Ahmed Awad
Approximately 100 completed nephrology studies supporting sponsors across the Sequoia network.
Vaccines
Dr. Carlos Fierro
20+ years of vaccine research experience and 300+ vaccine studies supporting sponsors across the Sequoia network.
Explore clinical trials currently enrolling across the Sequoia network.
Every Sequoia location operates under shared SOPs, centralized recruitment, a single CTMS, and coordinated study management, providing sponsors with one consistent experience across the network.
JCCT, a Sequoia Company
Kansas City
For sponsors and participants researching clinical trials in Kansas City, the JCCT site in Lenexa offers a 34-bed inpatient facility, 13 outpatient exam rooms, an onsite pharmacy, and a PBMC lab in a 32,000 sq. ft. BSL-2 facility, with deep experience in vaccine and Phase 1 and First-in-Human research.
Juno Research, a Sequoia Company
Houston
For sponsors and participants exploring clinical trials in Houston, Sequoia’s Juno Research sites have completed 100+ trials, bringing a 75-80% minority patient population and more than 50,000 active patient charts, expanding access to clinical trial research for underrepresented communities. The sites are anchored by Dr. Vega's GLP-1, metabolic, and endocrine research program.
Meet our Principal Investigators
Dr. Fierro
Vaccines
Chief Scientific Officer (CSO) with 20+ years of dedicated vaccine research experience.
Dr. Vega
Endocrinology / Metabolic
Board-certified endocrinologist leading the network's GLP-1 and metabolic program in Houston.
Dr. Awad
Nephrology
Board-certified nephrologist leading the network’s nephrology research program.
Dr. Heath Wilt
Cardiovascular / Cardiometabolic
Board-certified cardiologist bringing cardiovascular expertise to the network.
Dr. Thomas Kreamer
Chief Medical Officer (CMO)
Full-time CMO providing medical oversight across every study in the Sequoia network.
Clinical Trials currently enrolling across our network.
See which studies are currently enrolling near you in Kansas City and Houston.
Let's Talk About Your Next Study
Most site networks promise enrollment and quality. Sequoia can show you the FDA audit record, investigator credentials, sponsor relationships, and enrollment infrastructure behind the claim.
Frequently Asked Questions
What is a clinical research site network?
A clinical research site network is an organization that operates multiple clinical research sites under shared leadership, quality systems, and operational infrastructure, rather than a single standalone location. Unlike an individual research site, a site network can run the same study across several locations at once, giving sponsors more consistent execution and faster enrollment. Unlike a contract research organization, which manages a trial on the sponsor's behalf, a site network provides the physical sites, investigators, and participants where the trial is actually conducted. Sequoia Clinical Research operates as a clinical research site network across Kansas City and Houston.
How does a clinical research site network help sponsors accelerate enrollment?
A clinical research site network accelerates enrollment by centralizing recruitment infrastructure and running the same study across multiple sites simultaneously, rather than relying on only a single location to hit a target. Sequoia's network includes 20+ dedicated recruiters and a shared database of 40,000 research subjects, allowing multiple sites to contribute toward one enrollment goal in parallel. PI-forward oversight keeps investigators personally engaged in recruitment and retention throughout the study, rather than leaving enrollment to administrative staff. Together, shared infrastructure and direct investigator involvement let the network enroll patients faster and more predictably than a single site working alone.
What therapeutic areas does Sequoia specialize in?
Sequoia's investigators have documented experience in four priority therapeutic areas: GLP-1, obesity, and metabolic research, led by Dr. Vega, whose Houston program has completed 40+ obesity and metabolic studies; cardiovascular and cardiometabolic studies, including hypertension and heart failure; nephrology research, led by Dr. Awad with approximately 100 completed trials; and vaccine research, led by Dr. Fierro with more than 20 years of experience. GLP-1 and metabolic research is the network's fastest-growing area, supported by the Juno sites in Houston.
What makes Sequoia's quality record different from other site networks?
Sequoia has completed five FDA inspections with zero 483 findings, a specific and verifiable compliance record. That record is supported by a dedicated, full-time Chief Medical Officer, Thomas Kreamer, who provides oversight across every study in the network, and by a PI-forward culture in which named investigators stay directly engaged in study conduct. This documented clinical research site quality is why FFL Partners selected Sequoia's JCCT organization after evaluating 30 clinical research platforms on FDA audit cleanliness and enrollment performance.
Where are Sequoia's clinical research sites located?
Sequoia Clinical Research operates clinical research sites in Kansas City and Houston. The Kansas City JCCT site offers 34-bed inpatient capacity and Phase 1 First-in-Human capabilities in a 32,000 square foot facility. The Houston Juno Research sites bring a 75-80% minority patient population and a therapeutic focus on GLP-1, metabolic, and endocrine research. Both locations operate under the same quality systems and standard operating procedures, giving sponsors a consistent experience across both sites.
How do I find a clinical trial at Sequoia near me?
You can browse currently enrolling clinical trials in Kansas City and Houston on Sequoia's study listing page. Each listing includes the condition being studied, the study location, and how to apply. Our team will walk you through eligibility and next steps once you submit interest in a study. New studies are added as they become available, so it's worth checking back if nothing matches your area right now.
How does Sequoia support sponsors with diversity enrollment mandates?
Sequoia's Houston Juno Research sites bring a patient population that is 75-80% minority, giving sponsors with FDA diversity enrollment mandates documented access to diverse participants. More than 50,000 active patient charts at the Houston sites support recruitment for studies with specific demographic requirements. This patient access is paired with the same centralized recruitment infrastructure used across the rest of the network, so diversity enrollment goals are supported by real database capacity, not aspiration alone.
What is the difference between a clinical research site network and a CRO?
A contract research organization manages a clinical trial on behalf of a sponsor, handling project management, regulatory submissions, and data oversight. A clinical research site network, by contrast, provides the physical locations, investigators, and participants where the trial is conducted. Sequoia Clinical Research is a site network, not a CRO: sponsors sometimes select Sequoia directly, while CROs bring it in as the execution partner for a study they have already been awarded. The distinction matters: a CRO's value is project management, while a site network's value is enrollment history, investigator credentials, and physical infrastructure.